|
Drug Therapy
Citations 311-320 of 471 total displayed.
|
Past content
(since Nov 1998):
|
- Observations
Hair Depigmentation During Chemotherapy With a Class III/V Receptor Tyrosine Kinase Inhibitor
- Shannon Routhouska; Anita C. Gilliam; Paradi Mirmirani
Arch Dermatol 2006; 142: 1477-1479.
[Abstract]
[Full text]
[PDF]
- Editorials
Livedoid Vasculopathy: What It Is and How the Patient Should Be Evaluated and Treated
- Jeffrey P. Callen
Arch Dermatol 2006; 142: 1481-1482.
[Extract]
[Full text]
[PDF]
- Correspondence
Transdermal Therapy for Erythromelalgia
- Jay S. Cohen
Arch Dermatol 2006; 142: 1508-a.
[Extract]
[Full text]
[PDF]
- Correspondence
Leukocytoclastic Vasculitis Masquerading as Hand-Foot Syndrome in a Patient Treated With Sorafenib
- Nancy M. Chung; Martin Gutierrez; Maria L. Turner
Arch Dermatol 2006; 142: 1510-1511.
[Extract]
[Full text]
[PDF]
- Correspondence
Long-term Control of Papular Dermatitis ("Dermal Hypersensitivity Reaction") With Mycophenolate Mofetil
- Scott L. Flugman
Arch Dermatol 2006; 142: 1512-1513.
[Extract]
[Full text]
[PDF]
- Correspondence
Cytokine-Release Syndrome Related to Rituximab Limited to Lesions and Excision Scars of Lesions of Primary Cutaneous Lymphoma
- Silvia Perez-Gala; Yolanda Delgado-Jimenez; Rebeca Goiriz; Javier Fraga; Amaro Garcia-Diez; Jesus Fernandez-Herrera
Arch Dermatol 2006; 142: 1516-1517.
[Extract]
[Full text]
[PDF]
- Studies
Dermatologic Adverse Effects of Lenalidomide Therapy for Amyloidosis and Multiple Myeloma
- Hans P. Sviggum; Mark D. P. Davis; S. Vincent Rajkumar; Angela Dispenzieri
Arch Dermatol 2006; 142: 1298-1302.
[Abstract]
[Full text]
[PDF]
- Observations
Antimicrobial Allergy From Polyvinyl Chloride Gloves
- Kristiina Aalto-Korte; Kristiina Alanko; Maj-Len Henriks-Eckerman; Riitta Jolanki
Arch Dermatol 2006; 142: 1326-1330.
[Abstract]
[Full text]
[PDF]
- The Cutting Edge
Severe Hidradenitis Suppurativa Treated With Adalimumab
- Danielle K. Moul; Neil J. Korman
Arch Dermatol 2006; 142: 1110-1112.
[Extract]
[Full text]
[PDF]
- Studies
1% Pimecrolimus, 0.005% Calcipotriol, and 0.1% Betamethasone in the Treatment of Intertriginous Psoriasis: A Double-blind, Randomized Controlled Study
- Alexander Kreuter; Anna Sommer; Julia Hyun; Matthias Bräutigam; Norbert H. Brockmeyer; Peter Altmeyer; Thilo Gambichler
Arch Dermatol 2006; 142: 1138-1143.
[Abstract]
[Full text]
[PDF]
|
|
